鼻咽癌實(shí)驗(yàn)室診斷指標(biāo)的相關(guān)性研究
[Abstract]:Objective EBV infection is closely related to the occurrence and development of nasopharyngeal carcinoma (NPC). EB virus infection can lead to the change of chromophore A expression. The purpose of this study was to investigate the clinical evaluation of EB virus DNA (EBV-DNA), serum sialic acid (SA), chromaffin A (CgA) and EB virus related antibodies, that is, EB virus early antigen immunoglobulin A (EBV-EA-IgA), EB virus shell antigen immunoglobulin A) (Rta protein antibody IgG (Rta-IgG), the expression product of immediate early gene BRLF1 during the cracking period of EBV-CA-IgA), EB virus) in the diagnosis of nasopharyngeal carcinoma (NPC). Methods the serum samples of 249 patients with nasopharyngeal carcinoma (NPC) were detected by case-control method and analyzed with 50 healthy subjects, 50 patients with benign rhinitis and 50 patients with positive EBV-CA-IgA. Results the serum levels of six indexes in patients with nasopharyngeal carcinoma were significantly higher than those in the control group. The sensitivity of EBV-EA-IgA,EBV-CA-IgA,Rta-IgG,EBV-DNA,SA,CgA to nasopharyngeal carcinoma patients was 31.37%, 76.47%, 67.65%, 64.71%, 58.82%, 74.51%, 96.0%, 98.0%, 98.0%, 98.0%, 98.0%, 98.0%, 98.0%, 98.0%, 98.0%, 98.0%, 98.0%, 98.0%, 98.0%, 98.0% and 98.0%, respectively. 84.0%, 54.0%. At the same time, two or more indexes were detected jointly. The results showed that the diagnostic sensitivity and specificity of nasopharyngeal carcinoma patients were 96.08% and 95% respectively. The levels of serum Rta-IgG and EBV-DNA in patients with nasopharyngeal carcinoma (NPC) were significantly decreased after treatment. Conclusion the detection of serum EBV-EA-IgA,EBV-CA-IgA,Rta-IgG,EBV-DNA,SA,CgA has high clinical practical value in the auxiliary diagnosis of nasopharyngeal carcinoma. It is necessary to carry out joint detection in laboratory diagnosis of nasopharyngeal carcinoma. EBV-DNA can reflect the development of nasopharyngeal carcinoma in time and can be used to monitor the curative effect of nasopharyngeal carcinoma patients, which is superior to Rta-IgG, EBV-CA-IgA,EBV-EA-IgA..
【學(xué)位授予單位】:北京協(xié)和醫(yī)學(xué)院
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2014
【分類(lèi)號(hào)】:R739.63
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 盧愿;金潤(rùn)明;孫立榮;龐秀英;隋愛(ài)華;李學(xué)榮;;特發(fā)性血小板減少性紫癜與EB病毒感染的關(guān)系[J];青島大學(xué)醫(yī)學(xué)院學(xué)報(bào);2008年06期
2 李凌;嗜鉻粒蛋白A檢測(cè)及其臨床意義[J];標(biāo)記免疫分析與臨床;2005年01期
3 譚毅菁;蘇錫康;崔金環(huán);區(qū)文華;薛雄燕;;鼻咽癌患者血清中VCA-IgA、EA-IgA、EBV-DNA評(píng)價(jià)的比較[J];重慶醫(yī)學(xué);2010年06期
4 蔡永林;鄭裕明;成積儒;王偉;張旖旎;王衛(wèi)華;吳英松;楊淑君;鐘偉銘;李軍;莫永坤;;EB病毒Rta/IgG、EBNA1/IgA、VCA/IgA及EA/IgA抗體與鼻咽癌分期的關(guān)系[J];南方醫(yī)科大學(xué)學(xué)報(bào);2010年03期
5 袁利群;葉劍榮;;EB病毒抗體檢測(cè)在兒童傳染性單核細(xì)胞增多癥診斷中的應(yīng)用[J];湖南師范大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2010年03期
6 曾剛毅;唐孝亮;鐘海軍;;實(shí)時(shí)熒光定量PCR法檢測(cè)鼻咽癌患者血漿游離EB病毒DNA的臨床應(yīng)用[J];檢驗(yàn)醫(yī)學(xué)與臨床;2008年10期
7 包葉江;徐笑紅;;VCA-IgA及EA-IgA在鼻咽癌診斷和放射治療中的意義[J];浙江臨床醫(yī)學(xué);2006年01期
8 劉明波,董淑華,唐平章;EB病毒相關(guān)性鼻咽癌的免疫治療進(jìn)展[J];實(shí)用癌癥雜志;2004年06期
9 陳天游;范行良;;EB病毒診斷學(xué)意義及其方法學(xué)進(jìn)展[J];微生物學(xué)免疫學(xué)進(jìn)展;2009年03期
10 郝邯生;王碗朋;;EB病毒感染與系統(tǒng)性紅斑狼瘡相關(guān)性研究[J];武警醫(yī)學(xué)院學(xué)報(bào);2009年05期
,本文編號(hào):2506437
本文鏈接:http://sikaile.net/yixuelunwen/yank/2506437.html